KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Income Quality Over TimeStable
Percentile Rank33
3Y CAGR-4.2%
5Y CAGR-11.5%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-4.2%/yr
Annual compound
5Y CAGR
-11.5%/yr
Recent acceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
20250.83+18.3%
20240.70-13.0%
20230.81-14.6%
20220.95+45.4%
20210.65-57.6%
20201.54-11.9%
20191.75+361.5%
2018-0.67-152.4%
20171.28+10.8%
20161.15-